Elevance Health Inc.
Elevance Health Reports Fourth Quarter and Full Year 2024 Financial Results
Summary
Elevance Health, Inc. reported its fourth quarter and full year 2024 financial results, showing a 6% increase in operating revenue for Q4 and a 3% increase for the full year. The company announced diluted EPS of $1.81 for Q4 and $25.68 for the full year, with a projected GAAP diluted EPS of $30.40 to $31.10 for FY 2025. The company also declared a first quarter 2025 dividend of $1.71 per share, a 5% increase from the previous quarter. Exhibit 99.1 provides detailed financial results and outlook.
Profitelligence Alerts
Get alerts for ELV
Be first to know when Elevance Health Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Elevance Health Inc.
Elevance Health Inc., formerly known as Anthem, is a prominent health insurance company in the United States. Its primary function is to provide a wide range of health insurance products and related services to a diverse customer base, including individuals, families, and businesses. Elevance Health focuses on enhancing health and well-being by offering managed care plans tailored to the varying needs of its clients. With a robust portfolio, Elevance Health caters to multiple sectors within the healthcare industry, influencing stakeholders such as healthcare providers, pharmaceutical companies, and medical technology firms. The company plays a critical role in the healthcare market by negotiating coverage terms, managing costs, and ensuring policyholders have access to necessary medical services. As one of the largest health insurers in the nation, Elevance Health holds significant market influence, contributing to shaping healthcare policies and practices through its vast network and strategic partnerships. By leveraging technology and data analytics, the company aims to improve patient outcomes, streamline insurance processes, and foster advancements in personalized healthcare solutions.
Official SEC Documents
Advertisement